The Pharmacy Guild of Australia recently released its 7th Community Pharmacy Agreement, a five-year deal that outlines the terms and conditions for the delivery of pharmacy programs and services in Australia. The agreement is set to take effect from July 1, 2020, and will run until June 30, 2025.

The 7th Community Pharmacy Agreement builds on the previous 6 agreements that have been in place since 1990. Its primary goal is to ensure access to quality pharmaceutical services for all Australians, particularly those in rural and remote areas. The agreement also aims to improve medication safety, reduce the cost of medicines, support the role of pharmacists as primary healthcare providers, and advance the pharmacy profession.

Under the new agreement, the Pharmacy Guild will receive $18.9 billion in funding from the Australian government. This funding will be used to support a range of programs and initiatives, including:

1. Medication management services – Pharmacists will be able to provide medication reviews and other services to patients with complex health needs.

2. Rural and remote healthcare – The agreement will provide additional funding to support pharmacies in rural and remote areas.

3. Community pharmacy innovation – The agreement will support the development of new pharmacy programs and services that improve patient outcomes.

4. Workforce development – The agreement will provide funding for workforce development programs, including training and education for pharmacists.

Overall, the 7th Community Pharmacy Agreement is a significant step forward for the pharmacy profession in Australia. It will provide funding and support for essential pharmacy services and initiatives that will benefit patients across the country. The agreement also recognizes the vital role that pharmacists play in the healthcare system and will help to advance the profession further.